Xencor’s Experimental Rheumatoid Arthritis Therapy Shows Promise, Preliminary Results Show
News, rheumatoid arthritis
Xencor, Inc., a biopharmaceutical company that specializes in developing monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer recently announced the preliminary results of their Phase ... Read more